THORNE HEALTHTECH INC (THRN) Stock Fundamental Analysis
NASDAQ:THRN - Nasdaq - US8852601090 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to THRN. THRN was compared to 37 industry peers in the Personal Care Products industry. Both the profitability and the financial health of THRN get a neutral evaluation. Nothing too spectacular is happening here. THRN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year THRN was profitable.
THRN had a positive operating cash flow in the past year.
1.2 Ratios
THRN has a better Return On Assets (7.20%) than 75.00% of its industry peers.
The Return On Equity of THRN (13.21%) is better than 75.00% of its industry peers.
With a Return On Invested Capital value of 4.69%, THRN perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for THRN is significantly below the industry average of 13.42%.
The last Return On Invested Capital (4.69%) for THRN is above the 3 year average (2.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROIC | 4.69% |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
1.3 Margins
THRN has a better Profit Margin (7.94%) than 70.00% of its industry peers.
THRN has a Operating Margin of 5.26%. This is comparable to the rest of the industry: THRN outperforms 55.00% of its industry peers.
Looking at the Gross Margin, with a value of 50.15%, THRN is in line with its industry, outperforming 47.50% of the companies in the same industry.
THRN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
THRN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
THRN has more shares outstanding than it did 1 year ago.
THRN has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.41 indicates that THRN is not in any danger for bankruptcy at the moment.
THRN has a Altman-Z score of 3.41. This is in the better half of the industry: THRN outperforms 67.50% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that THRN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.17, THRN perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.41 |
ROIC/WACC0.5
WACC9.44%
2.3 Liquidity
A Current Ratio of 2.41 indicates that THRN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.41, THRN is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
THRN has a Quick Ratio of 1.13. This is a normal value and indicates that THRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.13, THRN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 660.00% over the past year.
THRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.25%.
Measured over the past years, THRN shows a very strong growth in Revenue. The Revenue has been growing by 30.66% on average per year.
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
3.2 Future
THRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.06% yearly.
The Revenue is expected to grow by 21.84% on average over the next years. This is a very strong growth
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.82, the valuation of THRN can be described as expensive.
THRN's Price/Earnings ratio is a bit cheaper when compared to the industry. THRN is cheaper than 65.00% of the companies in the same industry.
THRN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
THRN is valuated correctly with a Price/Forward Earnings ratio of 16.38.
Based on the Price/Forward Earnings ratio, THRN is valued a bit cheaper than 77.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. THRN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 |
4.2 Price Multiples
THRN's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates THRN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as THRN's earnings are expected to grow with 55.06% in the coming years.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y46.48%
EPS Next 3Y55.06%
5. Dividend
5.1 Amount
No dividends for THRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.19
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.03%
Inst Owner Change0%
Ins Owners10.68%
Ins Owner Change0%
Market Cap550.67M
Analysts80
Price Target8.61 (-15.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-40.77%
Min EPS beat(2)-112.25%
Max EPS beat(2)30.72%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-112.25%
Max EPS beat(4)30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.13%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-9.72%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | 25.59 | ||
| P/B | 3.58 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.38
EY3.73%
EPS(NY)0.62
Fwd EY6.11%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.4
OCFY3.91%
SpS4.74
BVpS2.85
TBVpS2.2
PEG (NY)1.87
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROCE | 5.95% | ||
| ROIC | 4.69% | ||
| ROICexc | 5.07% | ||
| ROICexgc | 6.08% | ||
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% | ||
| FCFM | N/A |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)4.22%
ROICexc(5y)N/A
ROICexgc(3y)5.36%
ROICexgc(5y)N/A
ROCE(3y)3.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 590.87% | ||
| Cap/Sales | 14.33% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.41 |
F-Score5
WACC9.44%
ROIC/WACC0.5
Cap/Depr(3y)158.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
EBIT growth 1Y1143.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.89%
EBIT Next 3Y103.9%
EBIT Next 5YN/A
FCF growth 1Y-266.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.29%
OCF growth 3YN/A
OCF growth 5YN/A